AIG
VYGR icon

American International Group’s Voyager Therapeutics VYGR Stock Holding History

American International Group’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,397
Closed -$181K – 2682
2024
Q1 		$181K Buy
19,397
+3,610
+23% +$30.5K ﹤0.01% 2209
2023
Q4 		$133K Sell
15,787
-64
-0.4% -$464 ﹤0.01% 2393
2023
Q3 		$123K Buy
15,851
+564
+4% +$5.15K ﹤0.01% 2395
2023
Q2 		$175K Buy
+15,287
New +$158K ﹤0.01% 2255
2021
Q2 		– Sell
-15,062
Closed -$71 – 3280
2021
Q1 		$71 Buy
15,062
+39
+0.3% +$266 ﹤0.01% 2870
2020
Q4 		$107 Sell
15,023
-431
-3% -$4.14K ﹤0.01% 2627
2020
Q3 		$165K Sell
15,454
-352
-2% -$4.13K ﹤0.01% 2248
2020
Q2 		$199K Buy
15,806
+1,515
+11% +$17.6K ﹤0.01% 2126
2020
Q1 		$131K Sell
14,291
-826
-5% -$9.48K ﹤0.01% 2153
2019
Q4 		$211K Sell
15,117
-126
-0.8% -$1.83K ﹤0.01% 2189
2019
Q3 		$262K Sell
15,243
-107
-0.7% -$2.25K ﹤0.01% 2019
2019
Q2 		$418K Buy
15,350
+1,670
+12% +$38.2K ﹤0.01% 1805
2019
Q1 		$262K Sell
13,680
-444
-3% -$5.78K ﹤0.01% 2065
2018
Q4 		$133K Sell
14,124
-107
-0.8% -$1.37K ﹤0.01% 2435
2018
Q3 		$269K Buy
14,231
+256
+2% +$4.91K ﹤0.01% 2251
2018
Q2 		$273K Buy
13,975
+3,074
+28% +$60.8K ﹤0.01% 2189
2018
Q1 		$205K Sell
10,901
-586
-5% -$12.7K ﹤0.01% 2250
2017
Q4 		$191K Buy
11,487
+1,726
+18% +$29.6K ﹤0.01% 2343
2017
Q3 		$201K Buy
9,761
+730
+8% +$8.24K ﹤0.01% 2288
2017
Q2 		$81K Buy
9,031
+1,803
+25% +$18.1K ﹤0.01% 2850
2017
Q1 		$96K Buy
7,228
+480
+7% +$5.83K ﹤0.01% 2611
2016
Q4 		$86K Sell
6,748
-19
-0.3% -$244 ﹤0.01% 2685
2016
Q3 		$81.3K Buy
6,767
+10
+0.1% +$135 ﹤0.01% 2727
2016
Q2 		$74.3K Buy
6,757
+3,395
+101% +$41.5K ﹤0.01% 2796
2016
Q1 		$29K Buy
+3,362
New +$38.1K ﹤0.01% 4147

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

American International Group's VYGR Position: Q2 2024 in Review

American International Group sold out of Voyager Therapeutics (VYGR) in Q2 2024, closing a stake of 19,397 shares — an estimated $181K sold.

American International Group first reported a position in VYGR in Q1 2016 and held it in 25 quarters. The position peaked at $418K in Q2 2019. 127 funds tracked by Wall St. Rank hold VYGR as of Q2 2024.

  • American International Group reported no remaining Voyager Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 19,397 Voyager Therapeutics shares in Q2 2024, an estimated $181K.
  • American International Group first reported a position in Voyager Therapeutics in Q1 2016 and held it in 25 quarters.
  • American International Group's Voyager Therapeutics position peaked at $418K in Q2 2019.
  • 127 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.